Cargando…

Development and pre-clinical evaluation of a Zika virus diagnostic for low resource settings

INTRODUCTION: Zika virus (ZIKV) is a re-emerging flavivirus that poses a significant public health threat. ZIKV exhibits a wide array of non-vector borne human transmission routes, such as sexual transmission, transplacental transmission and blood transfusion. Detection and surveillance of ZIKV is c...

Descripción completa

Detalles Bibliográficos
Autores principales: Balea, Rickyle, Pollak, Nina M., Hobson-Peters, Jody, Macdonald, Joanne, McMillan, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694267/
http://dx.doi.org/10.3389/fmicb.2023.1214148
_version_ 1785153337687015424
author Balea, Rickyle
Pollak, Nina M.
Hobson-Peters, Jody
Macdonald, Joanne
McMillan, David J.
author_facet Balea, Rickyle
Pollak, Nina M.
Hobson-Peters, Jody
Macdonald, Joanne
McMillan, David J.
author_sort Balea, Rickyle
collection PubMed
description INTRODUCTION: Zika virus (ZIKV) is a re-emerging flavivirus that poses a significant public health threat. ZIKV exhibits a wide array of non-vector borne human transmission routes, such as sexual transmission, transplacental transmission and blood transfusion. Detection and surveillance of ZIKV is considered paramount in prevention of major outbreaks. With the majority of cases reported in low-resource locations, simple, low-cost detection methods are considered highly desirable. MATERIALS AND METHODS: Here we have developed a sensitive and specific ZIKV diagnostic using reverse transcription recombinase-aided amplification (RT-RAA) coupled with lateral flow detection (LFD) targeting a highly conserved region of the ZIKV NS1 gene. RESULTS: We show our rapid, isothermal-ZIKV-diagnostic (Iso-ZIKV-Dx) can detect 500 copies of synthetic ZIKV RNA/μL in under 30 min at a constant 39°C. Using simulated urine samples, we observed that Iso-ZIKV-Dx also detects as low as 34.28 RNA copies/reaction of ZIKV (MR766 strain). Specificity testing confirmed that our test does not detect any co-circulating flaviviruses (dengue, West Nile, Japanese encephalitis, Murray Valley encephalitis and yellow fever viruses) or chikungunya virus. Sample processing results show complete inactivation of ZIKV (MR766 strain) in 5 min at room temperature using our novel viral RNA sample preparation reagent. Furthermore, lateral flow strips testing demonstrates positive diagnoses in as little as 5 min in running buffer. DISCUSSION: Contrary to conventional RT-qPCR, our Iso-ZIKV-Dx does not require expensive machinery, specialised laboratory settings or extensively trained personnel. Pre-clinical evaluation demonstrates that our test exhibits robust, in-field capabilities without compromising sensitivity or specificity. When compared to the gold-standard RT-qPCR, our Iso-ZIKV-Dx test offers an array of applications that extend beyond diagnostics alone, including potential for surveillance and monitoring of ZIKV vector competency.
format Online
Article
Text
id pubmed-10694267
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106942672023-12-05 Development and pre-clinical evaluation of a Zika virus diagnostic for low resource settings Balea, Rickyle Pollak, Nina M. Hobson-Peters, Jody Macdonald, Joanne McMillan, David J. Front Microbiol Microbiology INTRODUCTION: Zika virus (ZIKV) is a re-emerging flavivirus that poses a significant public health threat. ZIKV exhibits a wide array of non-vector borne human transmission routes, such as sexual transmission, transplacental transmission and blood transfusion. Detection and surveillance of ZIKV is considered paramount in prevention of major outbreaks. With the majority of cases reported in low-resource locations, simple, low-cost detection methods are considered highly desirable. MATERIALS AND METHODS: Here we have developed a sensitive and specific ZIKV diagnostic using reverse transcription recombinase-aided amplification (RT-RAA) coupled with lateral flow detection (LFD) targeting a highly conserved region of the ZIKV NS1 gene. RESULTS: We show our rapid, isothermal-ZIKV-diagnostic (Iso-ZIKV-Dx) can detect 500 copies of synthetic ZIKV RNA/μL in under 30 min at a constant 39°C. Using simulated urine samples, we observed that Iso-ZIKV-Dx also detects as low as 34.28 RNA copies/reaction of ZIKV (MR766 strain). Specificity testing confirmed that our test does not detect any co-circulating flaviviruses (dengue, West Nile, Japanese encephalitis, Murray Valley encephalitis and yellow fever viruses) or chikungunya virus. Sample processing results show complete inactivation of ZIKV (MR766 strain) in 5 min at room temperature using our novel viral RNA sample preparation reagent. Furthermore, lateral flow strips testing demonstrates positive diagnoses in as little as 5 min in running buffer. DISCUSSION: Contrary to conventional RT-qPCR, our Iso-ZIKV-Dx does not require expensive machinery, specialised laboratory settings or extensively trained personnel. Pre-clinical evaluation demonstrates that our test exhibits robust, in-field capabilities without compromising sensitivity or specificity. When compared to the gold-standard RT-qPCR, our Iso-ZIKV-Dx test offers an array of applications that extend beyond diagnostics alone, including potential for surveillance and monitoring of ZIKV vector competency. Frontiers Media S.A. 2023-11-20 /pmc/articles/PMC10694267/ http://dx.doi.org/10.3389/fmicb.2023.1214148 Text en Copyright © 2023 Balea, Pollak, Hobson-Peters, Macdonald and McMillan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Balea, Rickyle
Pollak, Nina M.
Hobson-Peters, Jody
Macdonald, Joanne
McMillan, David J.
Development and pre-clinical evaluation of a Zika virus diagnostic for low resource settings
title Development and pre-clinical evaluation of a Zika virus diagnostic for low resource settings
title_full Development and pre-clinical evaluation of a Zika virus diagnostic for low resource settings
title_fullStr Development and pre-clinical evaluation of a Zika virus diagnostic for low resource settings
title_full_unstemmed Development and pre-clinical evaluation of a Zika virus diagnostic for low resource settings
title_short Development and pre-clinical evaluation of a Zika virus diagnostic for low resource settings
title_sort development and pre-clinical evaluation of a zika virus diagnostic for low resource settings
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694267/
http://dx.doi.org/10.3389/fmicb.2023.1214148
work_keys_str_mv AT balearickyle developmentandpreclinicalevaluationofazikavirusdiagnosticforlowresourcesettings
AT pollakninam developmentandpreclinicalevaluationofazikavirusdiagnosticforlowresourcesettings
AT hobsonpetersjody developmentandpreclinicalevaluationofazikavirusdiagnosticforlowresourcesettings
AT macdonaldjoanne developmentandpreclinicalevaluationofazikavirusdiagnosticforlowresourcesettings
AT mcmillandavidj developmentandpreclinicalevaluationofazikavirusdiagnosticforlowresourcesettings